The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...
-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...
Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this ...
Explore the viral claims about human DNA in McDonald's burgers and the truth behind these allegations. Learn about the ...
Josh Lauer explores the trends shaping sequencing, the science behind SBX technology, and how AXELIOS 1 is designed to ...
Most DNA extraction protocols were originally developed for manual pipetting and later adapted for liquid handlers. In ...
The state has a cutting-edge system built during COVID but that can detect other viruses and diseases.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
The new resources will accelerate research and discovery across multiple health disciplines. UNT Health Fort Worth has launched a new High Performance Comput ...
OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results